Valneva trims R&D footprint by shutting French facility
The consolidation comes a week after the vaccine specialist downgraded its 2025 guidance.
Business & Regulation
Genentech begins construction of North Carolina manufacturing site
Odyssey bails on public listing as US IPO landscape stutters
Pharma’s AI prospects get nudged into the future with EU’s AI act
EU Health Data Space strikes a chord in EU harmonisation plans
EU reshapes HTAs: is the industry ready for it?
Sanofi increases ownership stake partaking in pharma buyback trend
Flu vaccine strategy on the line as new US leaders anticipated to take charge
